These findings establish a DUOX2-ROS-microbiota axis in which epithelial DUOX2 amplifies oxidative stress, remodels the gut ecosystem, and promotes inflammation, and highlights DUOX2 suppression or ROS-sensitive <i>Parabacteroides</i> as potential redox-centric therapeutic strategies for CD. This evidence concerns the gene DUOX2 and Cowden disease.